Kuwae Shinobu, Miyakawa Ichiko, Doi Tomohiro
Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.
Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 4720, Takeda Mitsui, Hikari, Yamaguchi, 743-8502, Japan.
Cytotechnology. 2018 Jun;70(3):939-948. doi: 10.1007/s10616-017-0185-1. Epub 2018 Jan 11.
A chemically defined platform basal medium and feed media were developed using a single Chinese hamster ovary (CHO) cell line that produces a monoclonal antibody (mAb). Cell line A, which showed a peak viable cell density of 5.9 × 10 cells/mL and a final mAb titer of 0.5 g/L in batch culture, was selected for the platform media development. Stoichiometrically balanced feed media were developed using glucose as an indicator of cell metabolism to determine the feed rates of all other nutrients. A fed-batch culture of cell line A using the platform fed-batch medium yielded a 6.4 g/L mAb titer, which was 12-fold higher than that of the batch culture. To examine the applicability of the platform basal medium and feed media, three other cell lines (A16, B, and C) that produce mAbs were cultured using the platform fed-batch medium, and they yielded mAb titers of 8.4, 3.3, and 6.2 g/L, respectively. The peak viable cell densities of the three cell lines ranged from 1.3 × 10 to 1.8 × 10 cells/mL. These results show that the nutritionally balanced fed-batch medium and feeds worked well for other cell lines. During the medium development, we found that choline limitation caused a lower cell viability, a lower mAb titer, a higher mAb aggregate content, and a higher mannose-5 content. The optimal choline chloride to glucose ratio for the CHO cell fed-batch culture was determined. Our platform basal medium and feed media will shorten the medium-development time for mAb-producing cell lines.
使用一种产生单克隆抗体(mAb)的中国仓鼠卵巢(CHO)细胞系,开发了一种化学成分明确的基础培养基和补料培养基。选择细胞系A进行基础培养基开发,该细胞系在分批培养中显示出5.9×10个细胞/mL的峰值活细胞密度和0.5 g/L的最终mAb滴度。以葡萄糖作为细胞代谢指标,开发了化学计量平衡的补料培养基,以确定所有其他营养物质的补料速率。使用该平台补料培养基对细胞系A进行补料分批培养,得到了6.4 g/L的mAb滴度,比分批培养高12倍。为了检验该平台基础培养基和补料培养基的适用性,使用该平台补料培养基培养了另外三种产生mAb的细胞系(A16、B和C),它们分别产生了8.4、3.3和6.2 g/L的mAb滴度。这三种细胞系的峰值活细胞密度在1.3×10至1.8×10个细胞/mL之间。这些结果表明,营养平衡的补料分批培养基和补料对其他细胞系也很有效。在培养基开发过程中,我们发现胆碱限制会导致较低的细胞活力、较低的mAb滴度、较高的mAb聚集物含量和较高的甘露糖-5含量。确定了CHO细胞补料分批培养中氯化胆碱与葡萄糖的最佳比例。我们的平台基础培养基和补料培养基将缩短产生mAb的细胞系的培养基开发时间。